KALA BIO, INC. Preferred Stock, Shares Authorized
KALA BIO, INC. (KALA) had Preferred Stock, Shares Authorized of 5.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesAuthorized · last filed 2026-08-19
- 2026-06-30: Preferred Stock, Shares Authorized 5.00M shares.
- 2026-03-31: Preferred Stock, Shares Authorized 5.00M shares.
- 2025-12-31: Preferred Stock, Shares Authorized 5.00M shares.
- 2025-09-30: Preferred Stock, Shares Authorized 5.00M shares.
| Period end | Preferred Stock, Shares Authorized |
|---|---|
| 2026-06-30 | 5.00M shares 10-Q · filed 2026-08-19 |
| 2026-03-31 | 5.00M shares 10-Q · filed 2026-05-15 |
| 2025-12-31 | 5.00M shares 10-Q · filed 2026-08-19 |
| 2025-09-30 | 5.00M shares 10-Q · filed 2025-11-19 |
| 2025-06-30 | 5.00M shares 10-Q · filed 2025-08-08 |
| 2025-03-31 | 5.00M shares 10-Q · filed 2025-05-14 |
| 2024-12-31 | 5.00M shares 10-K · filed 2026-04-15 |
| 2024-09-30 | 5.00M shares 10-Q · filed 2024-11-12 |
| 2024-06-30 | 5.00M shares 10-Q · filed 2024-08-06 |
| 2023-12-31 | 5.00M shares 10-K · filed 2025-03-31 |
| 2023-06-30 | 5.00M shares 10-Q · filed 2023-08-04 |
| 2023-03-31 | 5.00M shares 10-Q · filed 2023-05-09 |
| 2022-12-31 | 5.00M shares 10-K · filed 2024-03-29 |
| 2021-12-31 | 5.00M shares 10-K · filed 2023-03-03 |
| 2020-12-31 | 5.00M shares 10-K · filed 2022-03-29 |
| 2019-12-31 | 5.00M shares 10-K · filed 2021-02-25 |
| 2018-12-31 | 5.00M shares 10-K · filed 2020-02-12 |
| 2018-09-30 | 5.00M shares 10-Q · filed 2018-11-08 |
| 2018-06-30 | 5.00M shares 10-Q · filed 2018-08-09 |
| 2018-03-31 | 5.00M shares 10-Q · filed 2018-05-10 |
| 2017-12-31 | 5.00M shares 10-K · filed 2019-03-12 |
| 2017-09-30 | 5.00M shares 10-Q · filed 2017-11-07 |
| 2017-07-25 | 5.00M shares 10-K · filed 2019-03-12 |
| 2016-12-31 | 0.00 shares 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |